A Comparison of Psychoanalytic Therapy and Cognitive Behavioral Therapy for Anxiety (Panic/Agoraphobia) and Personality Disorders (APD Study): Presentation of the RCT Study Design

Standard

A Comparison of Psychoanalytic Therapy and Cognitive Behavioral Therapy for Anxiety (Panic/Agoraphobia) and Personality Disorders (APD Study): Presentation of the RCT Study Design. / Benecke, Cord; Huber, Dorothea; Staats, Hermann; Zimmermann, Johannes; Henkel, Miriam; Deserno, Heinrich; Wiegand-Grefe, Silke; Schauenburg, Henning.

in: Z PSYCHOSOM MED PSYC, Jahrgang 62, Nr. 3, 09.2016, S. 252-69.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{16f2cb2df483455d8e8c48d548f7baad,
title = "A Comparison of Psychoanalytic Therapy and Cognitive Behavioral Therapy for Anxiety (Panic/Agoraphobia) and Personality Disorders (APD Study): Presentation of the RCT Study Design",
abstract = "OBJECTIVES: Anxiety disorders, most notably panic disorders and agoraphobia, are common mental disorders, and there is a high comorbidity with personality disorders. Randomized controlled trails addressing this highly relevant group of patients are missing.DESIGN: The multicenter Anxiety and Personality Disorders (APD) study investigates 200 patients with panic disorder and/or agoraphobia with comorbid personality disorder in a randomized control-group comparison of psychoanalytic therapy (PT) and cognitive behavioral therapy (CBT), including 100 patients in each group. Each patient will be examined over a period of six years, regardless of the duration of the individual treatment. The main issues that are addressed in this study are the comparison of the efficacy of PT and CBT in this special patient population, the comparison of the sustainability of the effects of PT and CBT, the comparison of the long-term cost-benefit-ratios of PT and CBT as well as the investigation of prescriptive patient characteristics for individualized treatment recommendations (differential indication).DISCUSSION: The APD study compares efficacy, sustainability, and cost-benefit-ratios of CBT and PT for anxiety plus personality disorders in a randomized controlled trail. The study design meets the requirements for an efficacy study for PT, which were recently defined.TRIAL REGISTRATION: Current Controlled Trials ISRCTN12449681.",
keywords = "Agoraphobia, Anxiety Disorders, Cognitive Therapy, Comorbidity, Follow-Up Studies, Humans, Panic Disorder, Personality Disorders, Psychoanalytic Therapy, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial",
author = "Cord Benecke and Dorothea Huber and Hermann Staats and Johannes Zimmermann and Miriam Henkel and Heinrich Deserno and Silke Wiegand-Grefe and Henning Schauenburg",
year = "2016",
month = sep,
doi = "10.13109/zptm.2016.62.3.252",
language = "English",
volume = "62",
pages = "252--69",
journal = "Z PSYCHOSOM MED PSYC",
issn = "1438-3608",
publisher = "Vandenhoeck and Ruprecht GmbH and Co. KG",
number = "3",

}

RIS

TY - JOUR

T1 - A Comparison of Psychoanalytic Therapy and Cognitive Behavioral Therapy for Anxiety (Panic/Agoraphobia) and Personality Disorders (APD Study): Presentation of the RCT Study Design

AU - Benecke, Cord

AU - Huber, Dorothea

AU - Staats, Hermann

AU - Zimmermann, Johannes

AU - Henkel, Miriam

AU - Deserno, Heinrich

AU - Wiegand-Grefe, Silke

AU - Schauenburg, Henning

PY - 2016/9

Y1 - 2016/9

N2 - OBJECTIVES: Anxiety disorders, most notably panic disorders and agoraphobia, are common mental disorders, and there is a high comorbidity with personality disorders. Randomized controlled trails addressing this highly relevant group of patients are missing.DESIGN: The multicenter Anxiety and Personality Disorders (APD) study investigates 200 patients with panic disorder and/or agoraphobia with comorbid personality disorder in a randomized control-group comparison of psychoanalytic therapy (PT) and cognitive behavioral therapy (CBT), including 100 patients in each group. Each patient will be examined over a period of six years, regardless of the duration of the individual treatment. The main issues that are addressed in this study are the comparison of the efficacy of PT and CBT in this special patient population, the comparison of the sustainability of the effects of PT and CBT, the comparison of the long-term cost-benefit-ratios of PT and CBT as well as the investigation of prescriptive patient characteristics for individualized treatment recommendations (differential indication).DISCUSSION: The APD study compares efficacy, sustainability, and cost-benefit-ratios of CBT and PT for anxiety plus personality disorders in a randomized controlled trail. The study design meets the requirements for an efficacy study for PT, which were recently defined.TRIAL REGISTRATION: Current Controlled Trials ISRCTN12449681.

AB - OBJECTIVES: Anxiety disorders, most notably panic disorders and agoraphobia, are common mental disorders, and there is a high comorbidity with personality disorders. Randomized controlled trails addressing this highly relevant group of patients are missing.DESIGN: The multicenter Anxiety and Personality Disorders (APD) study investigates 200 patients with panic disorder and/or agoraphobia with comorbid personality disorder in a randomized control-group comparison of psychoanalytic therapy (PT) and cognitive behavioral therapy (CBT), including 100 patients in each group. Each patient will be examined over a period of six years, regardless of the duration of the individual treatment. The main issues that are addressed in this study are the comparison of the efficacy of PT and CBT in this special patient population, the comparison of the sustainability of the effects of PT and CBT, the comparison of the long-term cost-benefit-ratios of PT and CBT as well as the investigation of prescriptive patient characteristics for individualized treatment recommendations (differential indication).DISCUSSION: The APD study compares efficacy, sustainability, and cost-benefit-ratios of CBT and PT for anxiety plus personality disorders in a randomized controlled trail. The study design meets the requirements for an efficacy study for PT, which were recently defined.TRIAL REGISTRATION: Current Controlled Trials ISRCTN12449681.

KW - Agoraphobia

KW - Anxiety Disorders

KW - Cognitive Therapy

KW - Comorbidity

KW - Follow-Up Studies

KW - Humans

KW - Panic Disorder

KW - Personality Disorders

KW - Psychoanalytic Therapy

KW - Comparative Study

KW - Journal Article

KW - Multicenter Study

KW - Randomized Controlled Trial

U2 - 10.13109/zptm.2016.62.3.252

DO - 10.13109/zptm.2016.62.3.252

M3 - SCORING: Journal article

C2 - 27594602

VL - 62

SP - 252

EP - 269

JO - Z PSYCHOSOM MED PSYC

JF - Z PSYCHOSOM MED PSYC

SN - 1438-3608

IS - 3

ER -